Avid Bioservices Inc (CDMO)

[biopharm]

Dilution of $75M sale of ATM at this price or any price higher is minimal impact to the overall future of this stock. I believe we have to look at the overall picture and with successful trials continuing into this year and fda approval this can "easily" handle the extra dilution .... that has not happened yet. What will the total shares be.... say 65M shares + additional 25M ... takes us to about 90M shares.

Lets just try and compare to a company that is almost in the same league... take EXEL that is also taking their cancer drug into Phase III later this year. EXEL has total shares out of about 108M shares and has risen recently from $2 to over $10 today. This is without Phase III even starting .... and without the pipeline as PPHM has... and without the experience that PPHM has in AVID.

Lets face it... PPHM is way undervalued and Blackrock is one of the first .. along with DART that has realized this and jumping on board. EXEL has close to 70% Institutional ownership and PPHM will be in the same position by years end.

Thats this year... 2011 all in my opinion and let the games begin. We are all here because we have our hard earned money in this stock and the hard work has been completed already by PPHM... this upcoming year is the marketing and presentation of results to FDA and hopeful approvals and lets just hope they present their trials well and there are too many positive signs over the past year that tells me... including BlackRock and DART that we are on the verge of a once known high risk stock.... about to reward the longs with a much higher high return on investment.

so taking us to $5... to $10... and popping to $20 by year end is very much possible! I've lost money and made money in many other stocks.... but this will be the one that many of us will talk about for a lifetime.